Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin

Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin

Abstract Background Glucocorticoid (GC)-induced hyperglycemia is characterized by elevated postprandial blood glucose, which commonly requires multiple insulin injections. We investigated whether a long-acting glucagon-like peptide-1 receptor agonist, dulaglutide (Dula), safely improved GC-induced h...

Full description

Bibliographic Details
Main Authors: Hiroyuki Uchinuma, Masashi Ichijo, Noriyuki Harima, Kyoichiro Tsuchiya
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Endocrine Disorders
Subjects:
Dulaglutide
Glucocorticoid-induced hyperglycemia
Diabetes mellitus
Insulin
Online Access:http://link.springer.com/article/10.1186/s12902-020-0542-5

Internet

http://link.springer.com/article/10.1186/s12902-020-0542-5

Similar Items